Yahoo Finance Top Ranked Value Stocks to Buy for December 30th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, December 30th:
Navios Maritime Partners L.P. (NMM): This owner and operator of dry cargo vessels has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 4.6% over the last 60 days.
Navios Maritime Partners LP Price and Consensus
Navios Maritime Partners LP price-consensus-chart | Navios Maritime Partners LP Quote
Navios Maritime has a price-to-earnings ratio (P/E) of 11.45 compared with 22.40 for the industry. The company possesses a Value Score of A.
Navios Maritime Partners LP PE Ratio (TTM)
Navios Maritime Partners LP pe-ratio-ttm | Navios Maritime Partners LP Quote
Verso Corporation (VRS): This producer of specialty and graphic papers, packaging and pulp has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 86.2% over the last 60 days.
Verso Corporation Price and Consensus
Verso Corporation price-consensus-chart | Verso Corporation Quote
Verso has a price-to-earnings ratio (P/E) of 5.65 compared with 10.10 for the industry. The company possesses a Value Score of A.
Verso Corporation PE Ratio (TTM)
Verso Corporation pe-ratio-ttm | Verso Corporation Quote
Innoviva, Inc. (INVA): This developer of pharmaceuticals has a Zacks Rank #1 (Strong Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 18.7% over the last 60 days.
Innoviva, Inc. Price and Consensus
Innoviva, Inc. price-consensus-chart | Innoviva, Inc. Quote
Innoviva has a price-to-earnings ratio (P/E) of 7.02 compared with 13.80 for the industry. The company possesses a Value Score of B.
Innoviva, Inc. PE Ratio (TTM)
Innoviva, Inc. pe-ratio-ttm | Innoviva, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
Find more top income stocks with some of our great premium screens.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Verso Corporation (VRS) : Free Stock Analysis Report
Navios Maritime Partners LP (NMM) : Free Stock Analysis Report
Innoviva, Inc. (INVA) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
